What does CUSIP 359616109 represent in this 13F holders report?

CUSIP 359616109 is the security identifier for FULC - Fulcrum Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held FULC - Fulcrum Therapeutics, Inc. - Common Stock in Q2 2022?

97 institutional investors reported FULC - Fulcrum Therapeutics, Inc. - Common Stock for Q2 2022. Use the holders table for investor-level position and value details.

Fulcrum Therapeutics, Inc. - Common Stock (FULC)

CUSIP: 359616109

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock
Shares outstanding: 67,171,444
Total 13F shares: 40,127,745
Share change: +624,911
Total reported value: $196,621,873
Put/Call ratio: 7.6%
Price per share: $4.90
Number of holders: 97
Value change: -$32,729,118
Number of buys: 54
Number of sells: 46

Quarterly Holders Quick Answers

What is CUSIP 359616109?
CUSIP 359616109 identifies FULC - Fulcrum Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 359616109:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of FULC - Fulcrum Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	9.1%	6,096,478	$144,182,000	—	31 Mar 2022	13F
TRV GP III, LLC	13F	Company	5.9%	3,962,202	$93,706,000	—	31 Mar 2022	13F
RTW INVESTMENTS, LP	13F	Company	5.4%	3,611,194	$85,405,000	—	31 Mar 2022	13F
COWEN AND COMPANY, LLC	13F	Company	5.1%	3,453,371	$81,672,000	—	31 Mar 2022	13F
SUVRETTA CAPITAL MANAGEMENT, LLC	13F	Company	3.9%	2,613,412	$61,807,000	—	31 Mar 2022	13F
TRV GP IV, LLC	13F	Company	3.5%	2,343,154	$55,416,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	3.3%	2,228,610	$52,707,000	—	31 Mar 2022	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	2.9%	1,950,000	$46,118,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	2.2%	1,503,821	$35,565,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	1.7%	1,108,424	$26,215,000	—	31 Mar 2022	13F
Logos Global Management LP	13F	Company	1.5%	1,000,000	$23,650,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	1%	675,954	$15,986,000	—	31 Mar 2022	13F
Deep Track Capital, LP	13F	Company	0.97%	650,000	$15,373,000	—	31 Mar 2022	13F
Mark J. Levin	3/4/5	Director, 10%+ Owner	— class O/S missing	4,038,002	$13,365,787	—	10 Nov 2021	3/4/5
D. E. Shaw & Co., Inc.	13F	Company	0.81%	547,404	$12,946,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.79%	530,137	$12,537,000	—	31 Mar 2022	13F
Polar Capital Holdings Plc	13F	Company	0.74%	500,000	$11,825,000	—	31 Mar 2022	13F
Rock Springs Capital Management LP	13F	Company	0.65%	434,590	$10,278,000	—	31 Mar 2022	13F
HARVARD MANAGEMENT CO INC	13F	Company	0.61%	410,714	$9,713,000	—	31 Mar 2022	13F
Point72 Asset Management, L.P.	13F	Company	0.48%	325,000	$7,686,000	—	31 Mar 2022	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.44%	294,118	$6,956,000	—	31 Mar 2022	13F
BESSEMER GROUP INC	13F	Company	0.43%	285,714	$6,757,000	—	31 Mar 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.42%	282,793	$6,688,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.38%	256,926	$6,076,000	—	31 Mar 2022	13F
Alphabet Inc.	13F	Company	0.38%	255,452	$6,041,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.35%	237,642	$5,621,000	—	31 Mar 2022	13F
Monashee Investment Management LLC	13F	Company	0.35%	236,991	$5,600,000	—	31 Mar 2022	13F
Sofinnova Investments, Inc.	13F	Company	0.34%	229,509	$5,428,000	—	31 Mar 2022	13F
Invesco Ltd.	13F	Company	0.33%	223,460	$5,284,000	—	31 Mar 2022	13F
Paradigm Biocapital Advisors LP	13F	Company	0.32%	212,961	$5,037,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.43%	291,332	$4,970,000	—	31 Mar 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.3%	200,386	$4,739,000	—	31 Mar 2022	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	0.3%	200,000	$4,730,000	—	31 Mar 2022	13F
LORD, ABBETT & CO. LLC	13F	Company	0.28%	188,651	$4,462,000	—	31 Mar 2022	13F
Parkman Healthcare Partners LLC	13F	Company	0.24%	164,453	$3,889,000	—	31 Mar 2022	13F
Opaleye Management Inc.	13F	Company	0.2%	136,000	$3,216,000	—	31 Mar 2022	13F
FIDUCIARY TRUST CO	13F	Company	0.2%	132,472	$3,133,000	—	31 Mar 2022	13F
FIRST MANHATTAN CO. LLC.	13F	Company	0.17%	116,622	$2,758,000	—	31 Mar 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.17%	112,203	$2,654,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.15%	100,639	$2,380,000	—	31 Mar 2022	13F
NORGES BANK	13F	Company	0.13%	87,100	$2,059,915	—	31 Mar 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.13%	85,500	$2,022,000	—	31 Mar 2022	13F
Tekla Capital Management LLC	13F	Company	0.12%	77,293	$1,828,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.11%	72,209	$1,708,000	—	31 Mar 2022	13F
Cinctive Capital Management LP	13F	Company	0.1%	66,120	$1,564,000	—	31 Mar 2022	13F
Swiss National Bank	13F	Company	0.09%	62,400	$1,476,000	—	31 Mar 2022	13F
FRED ALGER MANAGEMENT, LLC	13F	Company	0.07%	48,921	$1,157,000	—	31 Mar 2022	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.06%	39,600	$936,000	—	31 Mar 2022	13F
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F	Company	0.12%	82,741	$833,000	—	31 Mar 2022	13F
COUNTRY TRUST BANK	13F	Company	0.05%	35,186	$832,000	—	31 Mar 2022	13F

Institutional Holders of Fulcrum Therapeutics, Inc. - Common Stock (FULC) as of Q2 2022

As of 30 Jun 2022, Fulcrum Therapeutics, Inc. - Common Stock (FULC) was held by 97 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 40,127,745 shares. The largest 10 holders included FMR LLC, TRV GP III, LLC, RTW INVESTMENTS, LP, SUVRETTA CAPITAL MANAGEMENT, LLC, BlackRock Inc., COWEN AND COMPANY, LLC, TRV GP IV, LLC, Point72 Asset Management, L.P., Logos Global Management LP, and VANGUARD GROUP INC. This page lists 97 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

104

Q2 2022 holders

Holder diff

-7

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.